![PDF) Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33) PDF) Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)](https://i1.rgstatic.net/publication/336286008_Implantable_cardioverter_defibrillator_and_cardiac_resynchronization_therapy_use_in_New_Zealand_ANZACS-QI_33/links/5d99dc73299bf1c363fbba2d/largepreview.png)
PDF) Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
IS 13450-2-4 (2009): Medical electrical equipment, Part 2: Particular requirements for the safety , Section 4 Cardia Defibrillat
![Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator | Journal of the American College of Cardiology Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/e5ec6690-fb70-4dc2-953d-c5dd2973878b/fx1.jpg)
Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator | Journal of the American College of Cardiology
![PDF) Physical and Psychosocial concerns among patient living with Implantable Cardioverter Defibrillator attending tertiary Health care Facility PDF) Physical and Psychosocial concerns among patient living with Implantable Cardioverter Defibrillator attending tertiary Health care Facility](https://i1.rgstatic.net/publication/345813992_Physical_and_Psychosocial_concerns_among_patient_living_with_Implantable_Cardioverter_Defibrillator_attending_tertiary_Health_care_Facility/links/5faebac9299bf10c3678a319/largepreview.png)